Prescription amphetamines in people with opioid use disorder and co-occurring psychostimulant use disorder initiating buprenorphine: an analysis of treatment retention and overdose risk

Tardelli, V., Xu, K. Y., Bisaga, A., Levin, F. R., Fidalgo, T. M., & Grucza, R. A. (2023). Prescription amphetamines in people with opioid use disorder and co-occurring psychostimulant use disorder initiating buprenorphine: an analysis of treatment retention and overdose risk. BMJ Mental Health, 26(1), e300728. https://doi.org/10.1136/bmjment-2023-300728
Authors:
Vitor Tardelli
Kevin Y Xu
Adam Bisaga
Frances R Levin
Thiago M Fidalgo
Richard A Grucza
Affiliated Authors:
Adam Bisaga
Frances R Levin
Columbia Affiliation:
Subjects:
Buprenorphine (MeSH)
Drug Overdose (MeSH)
Drug-Related Side Effects and Adverse Reactions (MeSH)
Opioid-Related Disorders (MeSH)
Author Keywords:
adult psychiatry
substance misuse
elink
Publication Type:
Article
Unique ID:
10.1136/bmjment-2023-300728
PMID:
37500184
DOI:
10.1136/bmjment-2023-300728
Journal:
BMJ Mental Health
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record

Record Created: